Related Experiment Video
Updated: Feb 23, 2026

09:09
Cryosectioning and Immunostaining Mouse Inner Ear Tissue: From Embryonic to Adult Stages
Published on: April 11, 2025
2.1K
Hearing loss as a risk factor for dementia: A systematic review
Rhett S Thomson1,2, Priscilla Auduong1,2, Alexander T Miller1,2
1Department of Surgery University of Utah Salt Lake City Utah U.S.A.
Laryngoscope Investigative Otolaryngology
|September 13, 2017
Summary
Hearing loss is linked to a higher risk of dementia in older adults. This systematic review found consistent evidence across multiple studies, highlighting the importance of addressing hearing health for cognitive well-being.
Area of Science:
- Gerontology
- Neuroscience
- Audiology
Background:
- Hearing loss is a common condition in older adults.
- Emerging evidence suggests a potential link between hearing impairment and cognitive decline.
- Understanding this association is crucial for public health initiatives.
Purpose of the Study:
- To systematically review existing evidence on hearing loss as a risk factor for dementia.
- To synthesize findings from studies investigating the relationship between hearing impairment and cognitive decline.
Main Methods:
- A systematic review of the PubMed database was performed.
- Search terms included "hearing loss" OR "presbycusis" AND "dementia" OR "cognitive decline".
- 17 articles meeting inclusion criteria, which evaluated the association between hearing loss and incident dementia or cognitive decline, were analyzed.
Main Results:
- All 17 included studies indicated an association between hearing loss and dementia or cognitive decline.
- Methods for assessing hearing loss and dementia varied, with peripheral auditory function and the Mini Mental State Exam (MMSE) being most common.
- Confounding variables like cardiovascular risk factors were frequently measured, though family history of dementia was less commonly assessed.
Conclusions:
- The reviewed studies consistently demonstrate that hearing loss is associated with an increased incidence of dementia in older adults.
- Despite methodological variations, the collective evidence supports a reliable link between impaired hearing and cognitive impairment.
Related Concept Videos
Dementia
597
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
597
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Pharmacodynamics in Geriatric Patients: Effects of Age
257
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
257

